Related Experiment Video
Updated: Feb 4, 2026

Planarian as an Animal Model for Experimental Acute Seizure
Published on: February 14, 2025
Basal Ganglia Calcification Secondary to Postsurgical Hypoparathyroidism Presenting With Seizures and Acute
Fahad S Alrashidi1, Ashwag H Mohajab2
1Department of Internal Medicine and Nephrology, Ad Diriyah Hospital, Riyadh Third Health Cluster, Riyadh, SAU.
Abstract:
Fahr syndrome is a rare neurologic condition characterized by bilateral intracranial calcifications, most commonly associated with metabolic or endocrine disorders, particularly hypoparathyroidism. We report a middle-aged woman with post-surgical hypoparathyroidism who presented with acute confusion and a generalized tonic-clonic seizure. Laboratory evaluation revealed severe hypocalcemia with undetectable parathyroid hormone levels. Non-contrast computed tomography (CT) of the head demonstrated extensive, symmetrical calcifications predominantly involving the basal ganglia, with additional thalamic and scattered subcortical involvement, consistent with Fahr syndrome. The patient was treated with intravenous calcium followed by oral calcium and vitamin D supplementation, with gradual neurologic improvement. This case emphasizes that basal ganglia calcifications in hypoparathyroidism are often an incidental radiologic finding and underscores the importance of early, sustained metabolic correction to prevent recurrent hypocalcemic complications and potential clinical progression.
More Related Videos
07:13Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
Published on: March 14, 2017
08:43Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome V: Nursing Management
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Secondary Active Transport